Co-expression patterns add information that either marker provides alone. CD45 identifies cells within the hematopoietic or leukocyte compartment, while CD11b highlights cells associated with myeloid populations and related leukocyte subsets. Examining both signals helps researchers distinguish marker-defined groups and compare how their relative abundance changes across infection, inflammation, or tissue injury.
In mixed samples, CD45 staining provides a way to separate leukocyte-associated measurements from signals arising in most nonimmune cells. Analysts can then examine CD11b within the CD45-positive compartment, reducing ambiguity when estimating myeloid-cell accumulation or leukocyte recruitment. This sequential interpretation makes co-expression data more biologically focused.
CD11b contributes functional context rather than serving only as a label. As an integrin involved in adhesion and migration, its presence connects marker-defined populations with processes that can alter where leukocytes are found. Consequently, CD11b and CD45 measurements can help relate immune-cell distribution to recruitment during infection, inflammation, or tissue injury.
Antibody staining provides the detection step, after which flow cytometry or tissue imaging can be used to examine the labeled cells. In flow cytometry, fluorescence intensity and co-expression patterns support population characterization; imaging applies the same marker information within tissue. The selected readout should match whether the study prioritizes cell profiling or tissue-associated patterns.
Tissue imaging is especially informative when the question concerns immune-cell distribution within an affected tissue rather than only the composition of a measured cell sample. CD11b and CD45 staining can show where marker-positive leukocytes are present in relation to tissue injury or inflammation. This adds spatial context to measurements obtained by flow cytometry.
Measuring these markers can provide evidence of changes in leukocyte recruitment, myeloid-cell accumulation, and immune responses. Comparisons between infection, inflammation, tissue injury, or experimental treatment conditions may show whether marker-defined populations increase, decrease, or shift in their co-expression patterns. These outcomes help connect cellular measurements with the biological condition under study.